Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$509M |
| 2 |
Mastercard
MA
|
+$404M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$401M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$302M |
| 5 |
Intuit
INTU
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$416M |
| 2 |
Coca-Cola
KO
|
+$394M |
| 3 |
Starbucks
SBUX
|
+$374M |
| 4 |
Salesforce
CRM
|
+$351M |
| 5 |
PNC Financial Services
PNC
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.34% |
| 2 | Financials | 9.88% |
| 3 | Consumer Discretionary | 8.94% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Dorman Products
DORM
$3.89B
| $835K | ﹤0.01% |
+6,930
| New | +$884K |
|
2052
Evolent Health
EVH
$534M
| $833K | ﹤0.01% |
+88,007
| New | +$889K |
|
2053
CALL
Arm
ARM
$255B
| $833K | ﹤0.01% |
7,800
+2,700
| +53% | +$377K |
|
|
MRSH
2054
Marsh
MRSH
$92.9B
| $831K | ﹤0.01% |
3,404
-7,270
| -68% | -$1.65M |
|
2055
Nano X Imaging
NNOX
$67.9M
| $827K | ﹤0.01% |
165,660
+146,366
| +759% | +$1.01M |
|
2056
Lantheus
LNTH
$6.58B
| $827K | ﹤0.01% |
8,475
-28,727
| -77% | -$2.69M |
|
2057
Titan International
TWI
$454M
| $827K | ﹤0.01% |
98,536
+87,650
| +805% | +$725K |
|
2058
XPeng
XPEV
$10.7B
| $826K | ﹤0.01% |
+39,849
| New | +$717K |
|
2059
CALL
CF Industries
CF
$19.6B
| $821K | ﹤0.01% |
10,500
-54,900
| -84% | -$4.61M |
|
2060
CALL
Humana
HUM
$46.4B
| $820K | ﹤0.01% |
3,100
-6,800
| -69% | -$1.84M |
|
2061
John Wiley & Sons Class A
WLY
$2.7B
| $817K | ﹤0.01% |
+18,331
| New | +$775K |
|
2062
Donaldson
DCI
$10.7B
| $816K | ﹤0.01% |
12,163
+7,730
| +174% | +$535K |
|
2063
PUT
PENN Entertainment
PENN
$2.45B
| $816K | ﹤0.01% |
50,000
| – | – |
|
2064
Centrus Energy
LEU
$3.53B
| $811K | ﹤0.01% |
13,035
-24,138
| -65% | -$2.03M |
|
|
CMA
2065
PUT
DELISTED
Comerica
CMA
| $809K | ﹤0.01% |
13,700
+3,000
| +28% | +$189K |
|
2066
CALL
Axsome Therapeutics
AXSM
$10.8B
| $805K | ﹤0.01% |
+6,900
| New | +$786K |
|
2067
EVgo
EVGO
$210M
| $802K | ﹤0.01% |
301,436
+289,440
| +2,413% | +$896K |
|
2068
MediaAlpha
MAX
$784M
| $802K | ﹤0.01% |
+86,754
| New | +$926K |
|
2069
YPF Sociedad Anonima ADS
YPF
$20.1B
| $799K | ﹤0.01% |
+22,813
| New | +$873K |
|
2070
Edison International
EIX
$28.5B
| $799K | ﹤0.01% |
+13,558
| New | +$779K |
|
2071
CALL
KKR & Co
KKR
$96.3B
| $798K | ﹤0.01% |
6,900
-55,000
| -89% | -$7.57M |
|
2072
PUT
Nutrien
NTR
$35.5B
| $795K | ﹤0.01% |
+16,000
| New | +$819K |
|
2073
PUT
CSX Corp
CSX
$95.3B
| $795K | ﹤0.01% |
27,000
-25,000
| -48% | -$794K |
|
2074
CALL
Lowe's Companies
LOW
$122B
| $793K | ﹤0.01% |
3,400
-3,300
| -49% | -$812K |
|
2075
Acco Brands
ACCO
$387M
| $793K | ﹤0.01% |
189,241
+27,473
| +17% | +$135K |
|
Similar funds
Dmitry Balyasny's Q1 2025 Portfolio in Review
As of Q1 2025, Dmitry Balyasny held 3,423 positions worth $60.5B, down 9.9% from $67.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Dmitry Balyasny withdrew a net $4.05B in Q1 2025, closing 697 positions and reducing 920 holdings. Its most notable exit was Starbucks, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in AutoZone worth $255M.
- Dmitry Balyasny's largest Q1 2025 buy was AutoZone: 66,934 shares worth $255M.
- Dmitry Balyasny added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $509M increase.
- Dmitry Balyasny's biggest Q1 2025 reduction was Arthur J. Gallagher & Co, cutting an estimated $416M.
- Dmitry Balyasny fully exited Starbucks in Q1 2025, selling an estimated $374M.
- Dmitry Balyasny's ten largest holdings make up 13% of its $60.5B portfolio in Q1 2025.
- Dmitry Balyasny opened 759 new positions and closed 697 in Q1 2025.
- Dmitry Balyasny's portfolio value fell 9.9% quarter-over-quarter to $60.5B.
Based on Balyasny Asset Management's 13F filing for Q1 2025, filed 15 May 2025.